Centers for Disease Control and Prevention: Unterschied zwischen den Versionen

Aus IntactiWiki
Zur Navigation springen Zur Suche springen
K
(sync'ed with English article and translated)
 
(Eine dazwischenliegende Version desselben Benutzers wird nicht angezeigt)
Zeile 1: Zeile 1:
{{NYT en}}
+
[[Image:CDC.jpg|right|thumb|Centers for Disease Control and Prevention]]
[[Image:CDC.jpg|right|thumb|Centers for Disease Control]]
+
Die '''{{FULLPAGENAME}}''' sind eine Agentur der [[USA]]-Regierung im Ministerium für Gesundheit und menschliche Dienste. Die {{FULLPAGENAME}} sind verantwortlich für den Schutz der öffentlichen Gesundheit in den [[USA]].
The '''Centers for Disease Control''' began to promote male circumcision as a HIV-prevention method as of February 2008.<ref>{{REFweb
+
Die {{FULLPAGENAME}} werden normalerweise nur "CDC" genannt. Ihr Hauptsitz ist in Atlanta, {{USSC|GA}}.
 +
 
 +
Die aktuelle Direktorin ist [[Rochelle Paula Walensky]], die einen {{MD}} von [[Johns Hopkins]] erhielt (bekannt für die finanzielle Unterstützung, die es von der [[Bill & Melinda Gates Foundation]] und ihrem Eintreten für männliche [[Beschneidung]] erhält) und einen {{MPH}} von der Harvard School of Public Health.<ref>{{REFweb
 +
|url=https://www.cdc.gov/about/leadership/director.htm
 +
|title=Rochelle P. Walensky, MD, MPH
 +
|last=
 +
|first=
 +
|init=CDC
 +
|publisher=Centers for Disease Control and Prevention
 +
|date=2021-10-06
 +
|accessdate=2021-08-28
 +
}}</ref> Dr. Walenksky präsentiert sich als Expertin für [[HIV]]. Dr. Walensky, Mitglied des Temple Emanuel of Newton, {{USSC|MA}}, mit drei Söhnen, die vermutlich gemäß dem [[Abrahamitischer Bund|abrahamischen Bund]] [[beschnitten]] sind, ist eine Biden-Beauftragte, die ihr Amt am 20. Januar 2021 angetreten hat.
 +
 
 +
== Die CDC und männliche Beschneidung ==
 +
 
 +
Die CDC begannen im Februar 2008, die männliche [[Beschneidung]] als eine [[HIV]]-Präventionsmethode zu fördern.<ref>{{REFweb
 
  |last=
 
  |last=
 
  |first=
 
  |first=
 
  |date=2008-02
 
  |date=2008-02
 
  |title=Male Circumcision and Risk for HIV Transmission and Other Health Conditions: Implications for the United States
 
  |title=Male Circumcision and Risk for HIV Transmission and Other Health Conditions: Implications for the United States
  |url=http://www.cdc.gov/hiv/resources/factsheets/circumcision.htm
+
|trans-title=Männliche Beschneidung und Risiko für HIV-Übertragung und andere Gesundheitszustände: Implikationen für die Vereinigten Staaten
 +
|language=Englisch
 +
  |url=https://www.cdc.gov/hiv/resources/factsheets/circumcision.htm
 
  |publisher=
 
  |publisher=
 
  |accessdate=2011-06-01
 
  |accessdate=2011-06-01
}}</ref> The [[CDC]] currently funds mass circumcision campaigns run by [[BOTUSA]] and the [[National Prevention Information Network]].<ref>{{REFweb
+
}}</ref> Die [[CDC]] finanzieren derzeit Massenbeschneidungskampagnen, die von [[BOTUSA]] durchgeführt werden.<ref>{{REFweb
 
  |last=
 
  |last=
 
  |first=
 
  |first=
 
  |date=2007-03
 
  |date=2007-03
 
  |title=Success Stories: Male Circumcision: A Question and Answer Session
 
  |title=Success Stories: Male Circumcision: A Question and Answer Session
 +
|trans-title=Erfolgsgeschichten: Männliche Beschneidung: Eine Frage-und-Antwort-Sitzung
 +
|language=Englisch
 
  |url=http://www.cdc.gov/botusa/Success-Stories/0307-MaleCircumcision-Botswana.htm
 
  |url=http://www.cdc.gov/botusa/Success-Stories/0307-MaleCircumcision-Botswana.htm
|publisher=
 
|accessdate=2011-06-01
 
}}</ref><ref>{{REFweb
 
|last=
 
|first=
 
|date=2011-09-01
 
|title=FundDisplay
 
|url=http://www.cdcnpin.org/Display/FundDisplay.asp?FundNbr=4285
 
 
  |publisher=
 
  |publisher=
 
  |accessdate=2011-06-01
 
  |accessdate=2011-06-01
 
}}</ref>
 
}}</ref>
  
== Proposed Guidelines for Counseling Male Patients and Parents ==
+
Die CDC scheint von männlicher [[Beschneidung]] besessen zu sein. Eine Suche auf der CDC-Website ergibt jetzt 760 Akten, in denen Beschneidung erwähnt wird. Es gibt offensichtlich eine starke Beschneidungskultur bei der CDC.
 
+
<!--
On 2 December 2014, the CDC released a [http://arclaw.org/news/cdc-releases-draft-first-ever-federal-guidelines-male-circumcision-public-commenting-period-ope proposed guideline] for counseling male patients and parents regarding male circumcision and the prevention of HIV infection, STIs and other health outcomes. The proposed guidelines seem to be in line with the AAP's Policy Statement of 2012 and also includes considerations for counseling of adolescents and adults in accordance with their HIV risk behavior, HIV status, sexual preferences and other factors. While the media tried to present these guidelines as an immediate endorsement of circumcision, the guidelines are far from recommending universal circumcision and in fact acknowledge that neonatal circumcision presents ethical concerns over the violation of autonomy. Read our analysis of the guidelines [http://circwatch.org/cdc-circumcision-and-misleading-headlines/ our analysis of the guidelines]
 
 
 
 
== Investigations by the Office of Inspector General (OIG) ==
 
== Investigations by the Office of Inspector General (OIG) ==
  
Zeile 43: Zeile 52:
 
}}</ref> The report read in part:
 
}}</ref> The report read in part:
  
{{Zitat
+
{{Citation
  |Text=Our review found that CDC did not always monitor recipients’ use of President’s Emergency Plan for AIDS Relief (PEPFAR) funds in accordance with departmental and other Federal requirements. CDC implements PEPFAR, working with ministries of health and other public health partners to combat HIV/AIDS by strengthening health systems and building sustainable HIV/AIDS programs in more than 75 countries in Africa, Asia, Central and South America, and the Caribbean. HHS receives PEPFAR funds from the Department of State through a memorandum of agreement.
+
  |Text=Our review found that CDC did not always monitor recipients’ use of President’s Emergency Plan for AIDS Relief (PEPFAR) funds in accordance with departmental and other Federal requirements. CDC implements PEPFAR, working with ministries of health and other public health partners to combat [[HIV]]/[[AIDS]] by strengthening health systems and building sustainable [[HIV]]/[[AIDS]] programs in more than 75 countries in Africa, Asia, Central and South America, and the Caribbean. HHS receives PEPFAR funds from the Department of State through a memorandum of agreement.
  
 
There was evidence that CDC performed some monitoring of recipients’ use of PEPFAR funds. However, most of the award files did not include all required documents or evidence to demonstrate that CDC performed required monitoring on all cooperative agreements. Of the 30 cooperative agreements in our sample, the award file for only 1 agreement contained all required documents. The remaining 29 award files were incomplete. In addition, 14 of 21 files were missing audit reports. (A report was not yet due for 9 of the 30 cooperative agreements.) The lack of required documentation demonstrates that CDC has not exercised proper stewardship over Federal PEPFAR funds because it did not consistently follow departmental and other Federal requirements in monitoring PEPFAR recipients.
 
There was evidence that CDC performed some monitoring of recipients’ use of PEPFAR funds. However, most of the award files did not include all required documents or evidence to demonstrate that CDC performed required monitoring on all cooperative agreements. Of the 30 cooperative agreements in our sample, the award file for only 1 agreement contained all required documents. The remaining 29 award files were incomplete. In addition, 14 of 21 files were missing audit reports. (A report was not yet due for 9 of the 30 cooperative agreements.) The lack of required documentation demonstrates that CDC has not exercised proper stewardship over Federal PEPFAR funds because it did not consistently follow departmental and other Federal requirements in monitoring PEPFAR recipients.
  |Autor=
+
  |Author=
  |Quelle=
+
  |Source=
 
}}
 
}}
  
Zeile 61: Zeile 70:
 
}}</ref> The report read in part:
 
}}</ref> The report read in part:
  
{{Zitat
+
{{Citation
 
  |Text=Although the majority of storage temperatures we independently measured during a 2 week period were within the required ranges, VFC vaccines stored by 76 percent of the 45 selected providers were exposed to inappropriate temperatures for at least 5 cumulative hours during that period. Exposure to inappropriate temperatures can reduce vaccine potency and efficacy, increasing the risk that children are not provided with maximum protection against preventable diseases. Thirteen providers stored expired vaccines together with nonexpired vaccines, increasing the risk of mistakenly administering the expired vaccine. Finally, the selected providers generally did not meet vaccine management requirements or maintain required documentation. Similarly, none of the five selected grantees met all VFC program oversight requirements, and grantee site visits were not effective in ensuring that providers met vaccine management requirements over time.
 
  |Text=Although the majority of storage temperatures we independently measured during a 2 week period were within the required ranges, VFC vaccines stored by 76 percent of the 45 selected providers were exposed to inappropriate temperatures for at least 5 cumulative hours during that period. Exposure to inappropriate temperatures can reduce vaccine potency and efficacy, increasing the risk that children are not provided with maximum protection against preventable diseases. Thirteen providers stored expired vaccines together with nonexpired vaccines, increasing the risk of mistakenly administering the expired vaccine. Finally, the selected providers generally did not meet vaccine management requirements or maintain required documentation. Similarly, none of the five selected grantees met all VFC program oversight requirements, and grantee site visits were not effective in ensuring that providers met vaccine management requirements over time.
  |Autor=
+
  |Author=
  |Quelle=
+
  |Source=
 
}}
 
}}
  
Zeile 77: Zeile 86:
 
}}</ref>. The report read in part:
 
}}</ref>. The report read in part:
  
{{Zitat
+
{{Citation
  |Text=DC's office in Windhoek, Namibia (CDC Namibia), is responsible for PEPFAR funds awarded to government agencies and for-profit and nonprofit organizations (recipients) in Namibia.
+
  |Text=CDC's office in Windhoek, Namibia (CDC Namibia), is responsible for PEPFAR funds awarded to government agencies and for-profit and nonprofit organizations (recipients) in Namibia.
  
 
Our audit found that CDC Namibia did not always monitor recipients' use of PEPFAR funds in accordance with HHS and other Federal requirements. There was evidence that CDC Namibia performed some monitoring of recipients' use of PEPFAR funds. However, most of the recipient cooperative agreement files did not include required documents or evidence that CDC Namibia had monitored all cooperative agreements. CDC Namibia did not consistently monitor the cooperative agreements in accordance with HHS and other Federal requirements because it did not have written policies and procedures for the monitoring process. As a result, CDC Namibia did not have assurance that PEPFAR funds were used as intended by law.
 
Our audit found that CDC Namibia did not always monitor recipients' use of PEPFAR funds in accordance with HHS and other Federal requirements. There was evidence that CDC Namibia performed some monitoring of recipients' use of PEPFAR funds. However, most of the recipient cooperative agreement files did not include required documents or evidence that CDC Namibia had monitored all cooperative agreements. CDC Namibia did not consistently monitor the cooperative agreements in accordance with HHS and other Federal requirements because it did not have written policies and procedures for the monitoring process. As a result, CDC Namibia did not have assurance that PEPFAR funds were used as intended by law.
  |Autor=
+
  |Author=
  |Quelle=
+
  |Source=
 
}}
 
}}
  
On the 12 February 2013, the OIG published a report critical of the CDC South Africa Office's failure to properly monitor recipients' use of [[PEPFAR]] funds<ref>{{REFweb
+
On 12 February 2013, the OIG published a report critical of the CDC South Africa Office's failure to properly monitor recipients' use of [[PEPFAR]] funds<ref>{{REFweb
 
  |last=
 
  |last=
 
  |first=
 
  |first=
  |date=2013-02
+
  |date=2013-02-12
 
  |title=The Centers for Disease Control and Prevention's South Africa Office Did Not Always Properly Monitor Recipients' Use of the President's Emergency Plan for AIDS Relief Funds (Audit A-04-12-04022)
 
  |title=The Centers for Disease Control and Prevention's South Africa Office Did Not Always Properly Monitor Recipients' Use of the President's Emergency Plan for AIDS Relief Funds (Audit A-04-12-04022)
 
  |url=http://oig.hhs.gov/oas/reports/region4/41204022.pdf
 
  |url=http://oig.hhs.gov/oas/reports/region4/41204022.pdf
Zeile 95: Zeile 104:
 
}}</ref>. The report read in part:
 
}}</ref>. The report read in part:
  
{{Zitat
+
{{Citation
  |Titel=
+
  |Title=
 
  |Text=Our audit found that CDC South Africa did not always monitor recipients' use of PEPFAR funds in accordance with HHS and other Federal requirements. There was evidence that CDC South Africa performed some monitoring of recipients' use of PEPFAR funds. However, most of the recipient cooperative agreement files did not include required documents or evidence that CDC South Africa had monitored all cooperative agreements.
 
  |Text=Our audit found that CDC South Africa did not always monitor recipients' use of PEPFAR funds in accordance with HHS and other Federal requirements. There was evidence that CDC South Africa performed some monitoring of recipients' use of PEPFAR funds. However, most of the recipient cooperative agreement files did not include required documents or evidence that CDC South Africa had monitored all cooperative agreements.
  
 
CDC South Africa did not have written policies and procedures to help ensure that it consistently monitored the cooperative agreements for recipients in accordance with HHS and other Federal requirements. As a result, CDC South Africa did not have assurance that PEPFAR funds were used as intended by law.
 
CDC South Africa did not have written policies and procedures to help ensure that it consistently monitored the cooperative agreements for recipients in accordance with HHS and other Federal requirements. As a result, CDC South Africa did not have assurance that PEPFAR funds were used as intended by law.
  |Autor=
+
  |Author=
  |Quelle=
+
  |Source=
 
}}
 
}}
  
Zeile 108: Zeile 117:
 
  |last=
 
  |last=
 
  |first=
 
  |first=
  |date=2013-02
+
  |date=2013-02-04
 
  |title=Spotlight on... Grants Management and Oversight
 
  |title=Spotlight on... Grants Management and Oversight
 
  |url=https://oig.hhs.gov/newsroom/spotlight/2013/grants.asp
 
  |url=https://oig.hhs.gov/newsroom/spotlight/2013/grants.asp
Zeile 115: Zeile 124:
 
}}</ref>
 
}}</ref>
  
{{Zitat
+
{{Citation
  |Titel=President's Emergency Plan for AIDS Relief Funds
+
  |Title=President's Emergency Plan for AIDS Relief Funds
  |Text=The President's Emergency Plan for AIDS Relief (PEPFAR) program authorized $78 billion from 2003 through 2014 in support of international programs for prevention, treatment, and care to combat HIV/AIDS, tuberculosis, and malaria. OIG examined the funds spent through this program in a 2011 report focusing on whether the Centers for Disease Control and Prevention's (CDC) oversight met departmental and Federal regulations. OIG found that while CDC performed some oversight of recipients' fund use, most of the award files did not include all required documents or evidence to demonstrate that CDC performed required monitoring. Because of these concerns, OIG expanded its audits internationally to include CDC's monitoring of PEPFAR funds by offices in other countries as well as audits of recipient organizations abroad. OIG issued two audits on Namibia, one in 2012 and another in 2013, and has an additional eight audits conducted there and in South Africa and Vietnam that are near completion." OIG is also planning seven more audits of PEPFAR grantees in Ethiopia and Zambia for FY 2013.
+
  |Text=The President's Emergency Plan for AIDS Relief (PEPFAR) program authorized $78 billion from 2003 through 2014 in support of international programs for prevention, treatment, and care to combat [[HIV]]/[[AIDS]], tuberculosis, and malaria. OIG examined the funds spent through this program in a 2011 report focusing on whether the Centers for Disease Control and Prevention's (CDC) oversight met departmental and Federal regulations. OIG found that while CDC performed some oversight of recipients' fund use, most of the award files did not include all required documents or evidence to demonstrate that CDC performed required monitoring. Because of these concerns, OIG expanded its audits internationally to include CDC's monitoring of PEPFAR funds by offices in other countries as well as audits of recipient organizations abroad. OIG issued two audits on Namibia, one in 2012 and another in 2013, and has an additional eight audits conducted there and in South Africa and Vietnam that are near completion." OIG is also planning seven more audits of PEPFAR grantees in Ethiopia and Zambia for FY 2013.
  |Autor=
+
  |Author=
  |Quelle=
+
  |Source=
 +
}}
 +
-->
 +
== Vorgeschlagene Richtlinien für die Beratung männlicher Patienten und Eltern ==
 +
 
 +
Am 2. Dezember 2014 veröffentlichte die CDC eine anonyme [https://www.arclaw.org/wp-content/uploads/CDC-2014-0012-0003.pdf vorgeschlagene Richtlinie] zur Beratung männlicher Patienten und Eltern bezüglich männlicher [[Beschneidung]] und die Prävention von [[HIV]]-Infektionen, sexuell übertragbaren Krankheiten und anderen Gesundheitsfolgen, wobei die Autoren es ablehnten, ihre Namen zu nennen. Die vorgeschlagenen Richtlinien scheinen im Einklang mit der Grundsatzerklärung der AAP von 2012 zu stehen und enthalten auch Überlegungen zur Beratung von Jugendlichen und Erwachsenen in Übereinstimmung mit ihrem [[HIV]]-Risikoverhalten, [[HIV]]-Status, sexuellen Vorlieben und anderen Faktoren. Während die Medien versuchten, diese Richtlinien als sofortige Befürwortung der Beschneidung darzustellen, sind die Richtlinien weit davon entfernt, eine universelle Beschneidung zu empfehlen, und erkennen tatsächlich an, dass die Beschneidung von Neugeborenen ethische Bedenken hinsichtlich der Verletzung der Autonomie aufwirft.
 +
 
 +
== [[CircWatch]] ==
 +
* {{REFweb
 +
|url=http://circwatch.org/cdc-circumcision-and-misleading-headlines/
 +
|title=CircWatch offers an analysis of the CDC guidelines
 +
|trans-title=CircWatch bietet eine Analyse der CDC-Richtlinien
 +
|language=Englisch
 +
}}
 +
* {{REFweb
 +
|url=http://circwatch.org/tag/cdc/
 +
|title=Post about the CDC on CircWatch
 +
|trans-title=Posting über die CDC auf CircWatch
 +
|language=Englisch
 
}}
 
}}
  
== CircWatch ==
+
{{SEEALSO}}
* [http://circwatch.org/tag/cdc/ Post about the CDC on CircWatch]
+
* [[BOTUSA]]
  
 
{{LINKS}}
 
{{LINKS}}
* [http://www.cdc.gov Website of] [[CDC]]
+
* {{URLwebsite|https://www.cdc.gov/|2022-08-28}}
* [http://www.cdc.gov/BOTUSA/default.htm Website of] [[BOTUSA]]
+
* {{REFweb
* [http://www.cdcnpin.org/scripts/index.asp Website of] the [[CDC]] [[National Prevention Information Network]]
+
|url=https://www.circumcisionisafraud.com/strange-science-at-play-inside-the-cdc
 +
|title=Strange science at play inside the CDC
 +
|trans-title=Seltsame Wissenschaft im Spiel innerhalb der CDC
 +
|language=Englisch
 +
|last=Jones
 +
|first=Ryan
 +
|init=
 +
|author-link=Ryan Jones
 +
|website=Circumcision is a Fraud
 +
|date=2022-07-20
 +
|accessdate=2022-08-28
 +
}}
  
 +
{{ABBR}}
 
{{REF}}
 
{{REF}}
  
[[Kategorie:Organisationen]]
+
[[Kategorie:Organisation]]
  
 
[[Kategorie:Von CircLeaks]]
 
[[Kategorie:Von CircLeaks]]

Aktuelle Version vom 20. November 2022, 12:10 Uhr

Centers for Disease Control and Prevention

Die Centers for Disease Control and Prevention sind eine Agentur der USA-Regierung im Ministerium für Gesundheit und menschliche Dienste. Die Centers for Disease Control and Prevention sind verantwortlich für den Schutz der öffentlichen Gesundheit in den USA. Die Centers for Disease Control and Prevention werden normalerweise nur "CDC" genannt. Ihr Hauptsitz ist in Atlanta, GA.

Die aktuelle Direktorin ist Rochelle Paula Walensky, die einen M.D.[a 1] von Johns Hopkins erhielt (bekannt für die finanzielle Unterstützung, die es von der Bill & Melinda Gates Foundation und ihrem Eintreten für männliche Beschneidung erhält) und einen M.P.H.[a 2] von der Harvard School of Public Health.[1] Dr. Walenksky präsentiert sich als Expertin für HIV. Dr. Walensky, Mitglied des Temple Emanuel of Newton, MA, mit drei Söhnen, die vermutlich gemäß dem abrahamischen Bund beschnitten sind, ist eine Biden-Beauftragte, die ihr Amt am 20. Januar 2021 angetreten hat.

Die CDC und männliche Beschneidung

Die CDC begannen im Februar 2008, die männliche Beschneidung als eine HIV-Präventionsmethode zu fördern.[2] Die CDC finanzieren derzeit Massenbeschneidungskampagnen, die von BOTUSA durchgeführt werden.[3]

Die CDC scheint von männlicher Beschneidung besessen zu sein. Eine Suche auf der CDC-Website ergibt jetzt 760 Akten, in denen Beschneidung erwähnt wird. Es gibt offensichtlich eine starke Beschneidungskultur bei der CDC.

Vorgeschlagene Richtlinien für die Beratung männlicher Patienten und Eltern

Am 2. Dezember 2014 veröffentlichte die CDC eine anonyme vorgeschlagene Richtlinie zur Beratung männlicher Patienten und Eltern bezüglich männlicher Beschneidung und die Prävention von HIV-Infektionen, sexuell übertragbaren Krankheiten und anderen Gesundheitsfolgen, wobei die Autoren es ablehnten, ihre Namen zu nennen. Die vorgeschlagenen Richtlinien scheinen im Einklang mit der Grundsatzerklärung der AAP von 2012 zu stehen und enthalten auch Überlegungen zur Beratung von Jugendlichen und Erwachsenen in Übereinstimmung mit ihrem HIV-Risikoverhalten, HIV-Status, sexuellen Vorlieben und anderen Faktoren. Während die Medien versuchten, diese Richtlinien als sofortige Befürwortung der Beschneidung darzustellen, sind die Richtlinien weit davon entfernt, eine universelle Beschneidung zu empfehlen, und erkennen tatsächlich an, dass die Beschneidung von Neugeborenen ethische Bedenken hinsichtlich der Verletzung der Autonomie aufwirft.

CircWatch

Siehe auch

Weblinks

Abkürzungen

  1. REFweb Doctor of Medicine, Wikipedia (englisch). Abgerufen 14. Juni 2021.
  2. REFweb Master of Public Health oder Master of Philosophy in Public Health, Wikipedia (englisch). Abgerufen 14. Juni 2021.

Einzelnachweise

  1. REFweb (6. Oktober 2021). Rochelle P. Walensky, MD, MPH, Centers for Disease Control and Prevention. Abgerufen 28. August 2021.
  2. REFweb (Februar 2008). Male Circumcision and Risk for HIV Transmission and Other Health Conditions: Implications for the United States [Männliche Beschneidung und Risiko für HIV-Übertragung und andere Gesundheitszustände: Implikationen für die Vereinigten Staaten] (Englisch). Abgerufen 1. Juni 2011.
  3. REFweb (März 2007). Success Stories: Male Circumcision: A Question and Answer Session [Erfolgsgeschichten: Männliche Beschneidung: Eine Frage-und-Antwort-Sitzung] (Englisch). Abgerufen 1. Juni 2011.